132 related articles for article (PubMed ID: 34740838)
21. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Anayo L; Magnussen A; Perry A; Wood M; Curnow A
Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
[TBL] [Abstract][Full Text] [Related]
22. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
23. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
[TBL] [Abstract][Full Text] [Related]
24. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
[TBL] [Abstract][Full Text] [Related]
25. Imaging of hypoxia, oxygen consumption and recovery in vivo during ALA-photodynamic therapy using delayed fluorescence of Protoporphyrin IX.
Scholz M; Petusseau AF; Gunn JR; Shane Chapman M; Pogue BW
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101790. PubMed ID: 32344195
[TBL] [Abstract][Full Text] [Related]
26. eEF1A1 binds and enriches protoporphyrin IX in cancer cells in 5-aminolevulinic acid based photodynamic therapy.
Fan Z; Cui X; Wei D; Liu W; Li B; He H; Ye H; Zhu N; Wei X
Sci Rep; 2016 May; 6():25353. PubMed ID: 27150264
[TBL] [Abstract][Full Text] [Related]
27. Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment.
Schimanski A; Ebbert L; Sabel MC; Finocchiaro G; Lamszus K; Ewelt C; Etminan N; Fischer JC; Sorg RV
J Photochem Photobiol B; 2016 Oct; 163():203-10. PubMed ID: 27588717
[TBL] [Abstract][Full Text] [Related]
28. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
Nakanishi T; Ogawa T; Yanagihara C; Tamai I
J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
[TBL] [Abstract][Full Text] [Related]
29. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
30. Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.
Johnson RP; Chung CW; Jeong YI; Kang DH; Suh H; Kim I
Int J Nanomedicine; 2012; 7():2497-512. PubMed ID: 22679363
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of ABCB6 enhances protoporphyrin IX accumulation and photodynamic effect in human glioma.
Zhao SG; Chen XF; Wang LG; Yang G; Han DY; Teng L; Yang MC; Wang DY; Shi C; Liu YH; Zheng BJ; Shi CB; Gao X; Rainov NG
Ann Surg Oncol; 2013 Dec; 20(13):4379-88. PubMed ID: 22688660
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the emission spectra and cytotoxicity of TiO
Vejdani Noghreiyan A; Sazegar MR; Mousavi Shaegh SA; Sazgarnia A
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101770. PubMed ID: 32311544
[TBL] [Abstract][Full Text] [Related]
33. Protoporphyrin IX (PpIX) loaded PLGA nanoparticles for topical Photodynamic Therapy of melanoma cells.
da Silva DB; da Silva CL; Davanzo NN; da Silva Souza R; Correa RJ; Tedesco AC; Riemma Pierre MB
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102317. PubMed ID: 33940210
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
[TBL] [Abstract][Full Text] [Related]
35. Effect of LaF
Tavakkoli F; Zahedifar M; Sadeghi E
Photodiagnosis Photodyn Ther; 2018 Mar; 21():306-311. PubMed ID: 29331661
[TBL] [Abstract][Full Text] [Related]
36. Protoporphyrin IX formation after topical application of methyl aminolaevulinate and BF-200 aminolaevulinic acid declines with age.
Nissen CV; Philipsen PA; Wulf HC
Br J Dermatol; 2015 Sep; 173(3):760-6. PubMed ID: 25997508
[TBL] [Abstract][Full Text] [Related]
37. Cell accumulation and antileishmanial effect of exogenous and endogenous protoporphyrin IX after photodynamic treatment.
Mateus JE; Valdivieso W; Hernández IP; Martínez F; Páez E; Escobar P
Biomedica; 2014; 34(4):589-97. PubMed ID: 25504248
[TBL] [Abstract][Full Text] [Related]
38. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
[TBL] [Abstract][Full Text] [Related]
39. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
40. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]